(S)-(6,6′-二甲氧基联苯-2,2′-二基)双(二-2-呋喃基膦) | 145214-59-1

• 物质功能分类: 化学试剂 - 有机试剂 - 膦配体
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: (S)-(6,6′-二甲氧基联苯-2,2′-二基)双(二-2-呋喃基膦)
• 中文别名: (6,6'-二甲氧基-2,2'-联苯二基)二(二-2-呋喃基膦)
• 英文名称: (S)-(6,6’-dimethoxybiphenyl-2,2’-diyl)bis(di-2-furylphosphine)
• 英文别名: (S)-2-furyl-MeOBIPHEP；(S)-2-furanyl-MeO-BIPHEP；(S)-(+)-2,2'-bis(di-(2-furanyl)phosphino)-6,6'-dimethoxy-1,1'-biphenyl；(S)-MeO(furyl)BIPHEP；(S)-methoxy(furyl)biphep；(R)-(6,6'-Dimethoxybiphenyl-2,2'-diyl)bis(di-2-furylphosphine)；[2-[2-[bis(furan-2-yl)phosphanyl]-6-methoxyphenyl]-3-methoxyphenyl]-bis(furan-2-yl)phosphane
• CAS: 145214-59-1
• 化学式: C₃₀H₂₄O₆P₂
• 分子量: 542.464
• InChiKey: ABGYJVGTLXSMBM-UHFFFAOYSA-N

物化性质

• 沸点：
  587.5±50.0 °C(Predicted)
• 稳定性/保质期：
  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  6.5
• 重原子数：
  38
• 可旋转键数：
  9
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  71
• 氢给体数：
  0
• 氢受体数：
  6

安全信息

• WGK Germany：
  3
• 海关编码：
  29321900
• 危险性防范说明：
  P261,P280,P301+P312,P302+P352,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

---

Section 1: Product Identification
Chemical Name: (S)-(-)-2,2'-Bis(di-2-furanylphosphino)-6,6'-dimethoxy-1,1'-biphenyl, min. 97%
CAS Registry Number: 145214-59-1
Formula: C30H24O6P2
EINECS Number: none
Chemical Family: organophosphine ligand
Synonym: (S)-(+)-furyl-MeOBIPHEP

---

Section 2: Composition and Information on Ingredients
Ingredient CAS Number Percent ACGIH (TWA) OSHA (PEL)
Title compound 145214-59-1 100% no data no data

---

Section 3: Hazards Identification
Emergency Overview: Irritating to skin, eyes and respiratory tract.
Primary Routes of Exposure: Ingestion, inhalation, skin, eyes
Eye Contact: Causes irritation of the eyes.
Skin Contact: Causes irritation of the skin.
Inhalation: Irritating to the nose, mucous membranes and respiratory tract.
Ingestion: No information available on the physiological effects of ingestion. May be harmful if swallowed.
Acute Health Affects: Irritating to skin, eyes and respiratory tract.
Chronic Health Affects: No information on long-term chronic effects.
NTP: No
IARC: No
OSHA: No

---

SECTION 4: First Aid Measures
Immediately flush the eyes with copious amounts of water for at least 10-15 minutes. A victim may need
Eye Exposure:
assistance in keeping their eye lids open. Get immediate medical attention.
Wash the affected area with water. Remove contaminated clothes if necessary. Seek medical assistance if
Skin Exposure:
irritation persists.
Remove the victim to fresh air. Closely monitor the victim for signs of respiratory problems, such as difficulty
Inhalation:
in breathing, coughing, wheezing, or pain. In such cases seek immediate medical assistance.
Seek medical attention immediately. Keep the victim calm. Give the victim water (only if conscious). Induce
Ingestion:
vomiting only if directed by medical personnel.

---

SECTION 5: Fire Fighting Measures
Flash Point: none
Autoignition Temperature: none
Explosion Limits: none
Extinguishing Medium: carbon dioxide, dry powder or foam
If this product is involved in a fire, fire fighters should be equipped with a NIOSH approved positive pressure
Special Fire Fighting Procedures:
self-contained breathing apparatus and full protective clothing.
Hazardous Combustion and If involved in a fire, this material may emit irritating organic fumes
Decomposion Products:
Unusual Fire or Explosion Hazards: No unusual fire or explosion hazards.

---

SECTION 6: Accidental Release Measures
Spill and Leak Procedures: Small spills can be mixed with vermiculite or sodium carbonate and swept up.

---

SECTION 7: Handling and Storage
Handling and Storage: Store in a tightly sealed container. Keep in a cool, dry, well ventilated place.

---

SECTION 8: Exposure Controls and Personal Protection
Eye Protection: Always wear approved safety glasses when handling a chemical substance in the laboratory.
Skin Protection: Wear protective clothing and gloves.
Ventilation: Handle the material in an efficient fume hood.
If ventilation is not available a respirator should be worn. The use of respirators requires a Respirator
Respirator:
Protection Program to be in compliance with 29 CFR 1910.134.
Ventilation: Handle the material in an efficient fume hood.
Additional Protection: No additional protection required.

---

SECTION 9: Physical and Chemical Properties
Color and Form: off-white powder
Molecular Weight: 542.47
Melting Point: no data
Boiling Point: no data
Vapor Pressure: no data
Specific Gravity: no data
Odor: not determined
Solubility in Water: insoluble

---

SECTION 10: Stability and Reactivity
Stability: air and moisture stable
Hazardous Polymerization: no hazardous polymerization
Conditions to Avoid: none
Incompatibility: strong oxidizing agents
Decomposition Products: carbon monoxide, carbon dioxide, phosphorous oxides and organic fumes

---

SECTION 11: Toxicological Information
RTECS Data: No information available in the RTECS files.
Carcinogenic Effects: No data
Mutagenic Effects: No data
Tetratogenic Effects: No data

---

SECTION 12: Ecological Information
Ecological Information: No information available

---

SECTION 13: Disposal Considerations
Disposal: Dispose of according to local, state and federal regulations.

---

SECTION 14: Transportation
Shipping Name (CFR): Non-hazardous
Hazard Class (CFR): NA
Additional Hazard Class (CFR): NA
Packaging Group (CFR): NA
UN ID Number (CFR): NA
Shipping Name (IATA): Non-hazardous
Hazard Class (IATA): NA
Additional Hazard Class (IATA): NA
Packaging Group (IATA): NA
UN ID Number (IATA): NA

---

SECTION 15: Regulatory Information
TSCA: Not listed in the TSCA inventory
SARA (Title 313): Title compound not listed
Second Ingredient: none

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  二(氰基苯)二氯化钯 、 (S)-(6,6′-二甲氧基联苯-2,2′-二基)双(二-2-呋喃基膦) 以 甲苯 为溶剂， 反应 3.0h， 以67%的产率得到[(R)-(+)-2,2'-Bis(di-2-furanylphosphino)-6,6'-dimethoxy-1,1'-biphenyl]palladium(II) dichloride
  参考文献：
  名称：

  钯催化的丙炔取代中的立体控制：动力学拆分得到对映体富集的 1,5-烯炔和乙酸丙炔酯。

  摘要：

  与手性原料催化烯丙基-炔丙基交叉偶联过程中的动力学拆分可以通过手性钯催化剂来完成。这些反应可以从简单易得的起始原料中轻松获得对映体富集的烯炔产物。

  DOI：

  10.1002/adsc.201300720
• 作为产物：
  描述：

  (R)-(6,6'-dimethoxybiphenyl-2,2'-diyl)bis(di-2-furylphosphine oxide) 、 水 在 sodium hydroxide 、 三正丁胺 、 三氯硅烷 作用下， 以 5,5-dimethyl-1,3-cyclohexadiene 、 乙醇 、 二氯甲烷 为溶剂， 生成 (S)-(6,6′-二甲氧基联苯-2,2′-二基)双(二-2-呋喃基膦)
  参考文献：
  名称：

  Chirale phosphines

  摘要：

  该文提到了一种化合物，其化学式为##STR1##，其中R代表较低的烷基、较低的烷氧基或受保护的羟基，R.sup.1代表五元杂芳环，R.sup.2代表较低的烷基或较低的烷氧基，n代表数字0、1或2。化合物I的形式为与第VIII族金属形成的配合物，用作不对称氢化的催化剂，以及用于对手性选择性氢位移在非手性烯丙基系统中。

  公开号：

  US05274125A1
• 作为试剂：
  描述：

  肉桂基氯 、 2-肉桂基-4,4,5,5-四甲基-1,3,2-二氧杂硼烷 在 tris-(dibenzylideneacetone)dipalladium(0) 、 (S)-(6,6′-二甲氧基联苯-2,2′-二基)双(二-2-呋喃基膦) 、 cesium fluoride 作用下， 以 四氢呋喃 为溶剂， 反应 14.0h， 生成 1,6-diphenyl-hexa-1,5-diene 、 (3R,4R)-hexa-1,5-diene-3,4-diyldibenzene 、 3,4-diphenylhexa-1,5-diene 、 1,4-diphenyl-1,5-hexadiene
  参考文献：
  名称：

  Diastereocontrol in Asymmetric Allyl–Allyl Cross-Coupling: Stereocontrolled Reaction of Prochiral Allylboronates with Prochiral Allyl Chlorides

  摘要：

  Palladium-catalyzed allyl-ally cross-coupling was investigated with substituted prochiral allylic boronates. These reactions deliver products bearing adjacent stereocenters, and the issue of diastereocontrol is therefore paramount. Under appropriately modified conditions, this allyl allyl coupling strategy was found to apply to a range of substrates, generally occurring with high enantioselectivity (92:8 to >99:1 er) and good diastereoselection (4:1 to 14:1 dr).

  DOI：

  10.1021/ja2075967

文献信息

• METHOD FOR PRODUCING SPIROOXINDOLE DERIVATIVE
  申请人：DAIICHI SANKYO COMPANY, LIMITED

  公开号：US20160194331A1

  公开（公告）日：2016-07-07

  The present invention is intended to provide a method for efficiently producing and providing a compound having a spirooxindole skeleton, for example, a compound having a spirooxindole skeleton and having antitumor activity that inhibits the interaction between Mdm2 protein and p53 protein, or an intermediate thereof, using an asymmetric catalyst. A compound having an optically active tricyclic dispiroindole skeleton is efficiently obtained through a catalytic asymmetric 1,3-dipolar cycloaddition reaction using ketimine as a reaction substrate and using a chiral ligand and a Lewis acid.

  本发明旨在提供一种有效生产和提供具有螺环氧吲哚骨架的化合物的方法，例如，利用不对称催化剂制备具有螺环氧吲哚骨架并具有抗肿瘤活性的化合物，该化合物抑制Mdm2蛋白与p53蛋白之间的相互作用，或其中间体。通过使用酮亚胺作为反应底物，并使用手性配体和Lewis酸进行催化不对称1,3-二极环加成反应，有效地获得具有光学活性的三环二螺吲哚骨架的化合物。
• PYRROLIDINE DERIVATIVES
  申请人：Knust Henner

  公开号：US20110144081A1

  公开（公告）日：2011-06-16

  The present invention relates to compounds of formula wherein R 1 , R 2 , R 3 , R 4 , Z, and n are as defined herein or to a pharmaceutically active salt thereof. Compounds of the invention are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).

  本发明涉及以下式中的化合物，其中R1、R2、R3、R4、Z和n如本文所定义，或其药用活性盐。本发明的化合物是治疗抑郁症、疼痛、精神病、帕金森病、精神分裂症、焦虑症和注意力缺陷多动障碍（ADHD）的高潜力NK-3受体拮抗剂。
• [EN] PYRROLIDINE DERIVATIVES<br/>[FR] DÉRIVÉS DE PYRROLIDINE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2011085886A1

  公开（公告）日：2011-07-21

  The present invention relates to compounds of formula (I) or to a pharmaceutically active salt thereof. It has been found that the present compounds are high potential NK-3 receptor antagonists for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD).

  本发明涉及式(I)的化合物或其药用活性盐。已发现这些化合物是治疗抑郁症、疼痛、精神病、帕金森病、精神分裂症、焦虑和注意力缺陷多动障碍（ADHD）的高潜力NK-3受体拮抗剂。
• PIPERAZINE AMIDE DERIVATIVES
  申请人：Dehmlow Henrietta

  公开号：US20090048264A1

  公开（公告）日：2009-02-19

  The invention is concerned with novel piperazine amide derivatives of formula (I) wherein R 1 to R 11 , W, X and Y are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds bind to LXR alpha and LXR beta and can be used as medicaments.

  这项发明涉及一种新型哌嗪酰胺衍生物，其化学式为（I），其中R1至R11、W、X和Y如描述和索赔中定义，并且其生理上可接受的盐。这些化合物能够结合到LXRα和LXRβ，并可用作药物。
• [EN] METHOD FOR PRODUCING AN OPTICALLY ACTIVE NITRO COMPOUND<br/>[FR] PROCEDE DE PRODUCTION D'UN COMPOSE NITRO OPTIQUEMENT ACTIF
  申请人：CARREIRA ERICK M

  公开号：WO2004103951A1

  公开（公告）日：2004-12-02

  An optically active nitro compound having two hydrogen atoms on its α-cabon atom and having β-asymmetric carbon atom can be produced by making α, β-unsaturated nitroolefin having a hydrogen atom on its α-cabon atom react with at least two organosilicon compounds having at lest one silicon-hydrogen bond in the molecule in the presence of an asymmetric copper complex, or react with an organosilicon compound having at least one silicon-hydrogen bond in the molecule in the presence of an asymmetric copper complex and water.

  具有两个氢原子的α-碳原子和β-手性碳原子的光学活性硝基化合物可以通过使具有α-碳原子上的氢原子的α，β-不饱和硝基烯烃与至少两个分子中至少有一个硅-氢键的有机硅化合物在存在不对称铜配合物的情况下反应，或者在存在不对称铜配合物和水的情况下，使具有至少一个硅-氢键的有机硅化合物与α-碳原子上的氢原子反应来制备。